Beam Therapeutics Inc. Net Cash/Marketcap

Net Cash/Marketcap of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Cash/Marketcap growth rates and interactive chart.


Highlights and Quick Summary

Current Net Cash/Marketcap of Beam Therapeutics Inc. is $-0.16 (as of December 31, 2021)
  • Net Cash/Marketcap for the quarter ending September 30, 2022 was $-0.274 (a -24.78% decrease compared to previous quarter)
  • Year-over-year quarterly Net Cash/Marketcap increased by 71.26%
  • Annual Net Cash/Marketcap for 2021 was $-0.16 (a 216.24% increase from previous year)
  • Annual Net Cash/Marketcap for 2020 was $-0.0505 (a -89.88% decrease from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Cash/Marketcap of Beam Therapeutics Inc.

Most recent Net Cash/Marketcapof BEAM including historical data for past 10 years.

Interactive Chart of Net Cash/Marketcap of Beam Therapeutics Inc.

Beam Therapeutics Inc. Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0 $0.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology